潘纳克斯人参可以帮助保护身体免受空气中的颗粒物有害影响吗?
Tae Woo Kwon1,2, Yujeong Ha1,2, Hyo-Sung Jo1,2
1Department of Convergence Medical Science, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Journal of ginseng research
|July 7, 2025
概括
帕纳克斯人参可能会防止颗粒物 (PM) 的健康风险. 需要进一步的临床研究来确认其有效性,并开发用于预防和治疗PM诱导毒性的先进配方.
科学领域:
- 环境健康 环境健康
- 药理学 药理学是指药理学的学科.
- 自然产品研究 自然产品研究
背景情况:
- 空气中的颗粒物 (PM) 暴露会通过氧化应激,炎症和细胞死亡途径对健康产生不利影响.
- 由于其广泛的活动和较低的毒性,天然产品在食品和药物开发中越来越受欢迎.
- 帕纳克斯人参是一种众所周知的天然产品,新出现的证据表明它可以减轻PM诱导的毒性.
研究的目的:
- 审查Panax人参衍生物质对PM诱导的不良健康反应的保护作用.
- 讨论Panax人参在食品和药物开发中的潜力,以预防和治疗PM暴露后果.
- 确定当前研究的局限性,并建议未来的研究方向.
主要方法:
- 对调查帕纳克斯人参及其成分与颗粒物暴露有关的研究的文献综述.
- 分析了PM诱导毒性背后的机制以及人参衍生化合物的潜在抵消作用.
- 关于帕纳克斯人参的总提取物,素分数和非素分数的疗效的综合发现.
主要成果:
- 帕纳克斯人参衍生物质显示出减轻PM诱导的各种不良反应的潜力.
- 帕纳克斯人参的特定成分和分量表现出对细胞损伤和压力通路的保护作用.
- 有证据表明,帕纳克斯人参在缓解氧化应激,炎症和由PM引发的亡中发挥着作用.
结论:
- 帕纳克斯人参作为一种自然干预措施,有望应对与颗粒物暴露相关的健康风险.
- 进一步的研究,包括全面的临床试验和标准化的方法,对于验证疗效和优化治疗应用至关重要.
- 建议开发先进配方,以增强帕纳克斯人参对公共健康的保护潜力.
相关概念视频
Transmission-based Precautions II: Airborne and Protective Environment
1.5K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K
Antiasthma Drugs: Muscarinic Receptor Antagonists
468
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
468
Adrenergic Agonists: Mixed-Action Agents
899
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
899


